comparemela.com
  1. Home
  2. Live Updates
  3. Metastatic Prostate Cancer - Breaking News

Latest Breaking News On - Metastatic prostate cancer - Page 6 : comparemela.com

LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer

LYNPARZA combination reduced the risk of disease progression or death by 76% vs. abiraterone alone First PARP inhibitor approved in combination with a novel hormonal agent underscores clinically. | June 1, 2023

United kingdomNorth carolinaUnited statesComunidad autonoma de catalunaDave fredricksonEliav barrAndrew armstrongData monitoring committeeMerck coHead of global clinical developmentEuropean unionResearch laboratoriesDuke cancer instituteOncology group trialsMerck co incExecutive vice president

Nasr on the Need for Preclinical Models of Prostate Cancer Dormancy

Mostafa Nasr, PhD candidate, discusses the development of novel preclinical models of prostate cancer dormancy, and the significance of these outcomes may have on future research in metastatic prostate cancer.

Mostafa nasrMoffitt cancer centerOnclive tvMetastatic prostate cancerMouse modelProstate cancer dormancy

Scientists Shed Light on Mechanism That Plays a Role in Prostate Cancer

Scientists say new mechanism raises and lowers PSMA expression in prostate cancer cells.

Martin bakhtDana farber himisha beltranDana farber cancer instituteNature cancerProstate specific membrane antigen heterogeneityMetastatic prostate cancerHimisha beltran

Duran Duran to reunite with original guitarist Andy Taylor on new music project

The renowned British new wave group will be releasing new tracks featuring their friends and family.

United statesUnited kingdomBuckingham palaceAndy taylorLos angelesNaomi clarkeAndy buttertonAssociation duranPress associationWild boysFuture pastScissor sister jake shearsPlatinum jubileeCommonwealth gamesBritish summer timeHollywood high

THE PROSTATE CANCER FOUNDATION ANNOUNCES 2022 CHALLENGE AWARDS TOTALING MORE THAN $12 MILLION FOR PROSTATE CANCER RESEARCH

/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million.

United kingdomUnited statesDana farber cancer instituteSan diegoLos angelesSan franciscoSangeeta goswamiLorelei mucciBrent roseDavid quigleyDominic smiragliaHoward scherChristina dieli conwrightNigel monganDaniel georgeStacil vernick

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.